Comparison of neuroprotective effects of erythropoietin (EPO) and carbamylerythropoietin (CEPO) against ischemia-like oxygen-glucose deprivation (OGD) and NMDA excitotoxicity in mouse hippocampal slice cultures

Experimental Neurology

Volumn 204, Issue 1, 2007, Pages 106-117

  Montero, Maria ^a   Poulsen, Frantz Rom ^a   Noraberg, Jens ^a   Kirkeby, Agnete ^b   van Beek, Johan ^b   Leist, Marcel ^b,c   Zimmer, Jens ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b H LUNDBECK A S   (Denmark)

^c UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

Calpain; Glutamate receptors; Neuroprotection; Organotypic

Indexed keywords

CARBAMYLERYTHROPOIETIN; CYTOKINE; CYTOSKELETON PROTEIN; ERYTHROPOIETIN; FODRIN; GLUCOSE; N METHYL DEXTRO ASPARTIC ACID; OXYGEN; PROPIDIUM IODIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE MODEL; EXCITOTOXICITY; HIPPOCAMPUS; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; TISSUE CULTURE;

ANIMALS; ANIMALS, NEWBORN; BRAIN ISCHEMIA; CALPAIN; COLORING AGENTS; ERYTHROPOIETIN; EXCITATORY AMINO ACID AGONISTS; GLUCOSE; HIPPOCAMPUS; HYPOXIA, BRAIN; MICE; MICE, INBRED C57BL; MICROTUBULE-ASSOCIATED PROTEINS; N-METHYLASPARTATE; NEUROPROTECTIVE AGENTS; PROPIDIUM; TOLONIUM CHLORIDE;

EID: 33847300431     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2006.09.026     Document Type: Article

References (57)

1. Azuma M., David L.L., and Shearer T.R. Cysteine protease inhibitor e64 reduces the rate of formation of selenite cataract in the whole animal. Curr. Eye Res. 10 (1991) 657-666
2. Bernaudin M., Marti H.H., Roussel S., Divoux D., Nouvelot A., Mackenzie E.T., and Petit E. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 19 (1999) 643-651
3. Bernaudin M., Bellail A., Marti H.H., Yvon A., Vivien D., Duchatelle I., Mackenzie E.T., and Petit E. Neurons and astrocytes express EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brain. Glia. 30 (2000) 271-278
4. Bittorf T., Jaster R., Ludtke B., Kamper B., and Brock J. Requirement for JAK2 in erythropoietin-induced signalling pathways. Cell Signal 9 (1997) 85-89
5. Bittorf T., Sasse T., Wright M., Jaster R., Otte L., Schneider-Mergener J., and Brock J. cDNA cloning and functional analysis of a truncated STAT5a protein from autonomously growing FDCP-1 cells. Cell Signal 12 (2000) 721-730
6. Blaabjerg M., Baskys A., Zimmer J., and Vawter M.P. Changes in hippocampal gene expression after neuroprotective activation of group I metabotropic glutamate receptors. Brain Res. Mol. Brain Res. 117 (2003) 196-205
7. Bonde C., Noraberg J., and Zimmer J. Nuclear shrinkage and other markers of neuronal cell death after oxygen-glucose deprivation in rat hippocampal slice cultures. Neurosci. Lett. 327 (2002) 49-52
8. Brana C., Benham C.D., and Sundstrom L.E. Calpain activation and inhibition in organotypic rat hippocampal slice cultures deprived of oxygen and glucose. Eur. J. Neurosci. 11 (1999) 2375-2384
9. Brines M., and Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat. Rev. Neurosci. 6 (2005) 484-494
10. Brines M., Grasso G., Fiordaliso F., Sfacteria A., Ghezzi P., Fratelli M., Latini R., Xie Q.W., Smart J., Su-Rick C.J., Pobre E., Diaz D., Gomez D., Hand C., Coleman T., and Cerami A. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 14907-14912
11. Buemi M., Cavallaro E., Floccari F., Sturiale A., Aloisi C., Trimarchi M., Grasso G., Corica F., and Frisina N. Erythropoietin and the brain: from neurodevelopment to neuroprotection. Clin. Sci. (LOND). 103 (2002) 275-282
12. Buemi M., Caccamo C., Nostro L., Cavallaro E., Floccari F., and Grasso G. Brain and cancer: the protective role of erythropoietin. Med. Res. Rev. 25 (2005) 245-259
13. Campana W.M., Misasi R., and O'Brien J.S. Identification of a neurotrophic sequence in erythropoietin. Int. J. Mol. Med. 1 (1998) 235-241
14. Choi D.W. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci. 18 (1995) 58-60
15. Choi D.W., and Rothman S.M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13 (1990) 171-182
16. Chong Z.Z., Lin S.H., Kang J.Q., and Maiese K. Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8. J. Neurosci. Res. 71 (2003) 659-669
17. D'Andrea R.J., and Gonda T.J. A model for assembly and activation of the GM-CSF, IL-3 AND IL-5 receptors: insights from activated mutants of the common beta subunit. Exp. Hematol. 28 (2000) 231-243
18. Damen J.E., Wakao H., Miyajima A., Krosl J., Humphries R.K., Cutler R.L., and Krystal G. Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and stat5 activation. EMBO J. 14 (1995) 5557-5568
19. Davis L.E., Widness J.A., and Brace R.A. Renal and placental secretion of erythropoietin during anemia or hypoxia in the ovine fetus. Am. J. Obstet. Gynecol. 189 (2003) 1764-1770
20. Digicaylioglu M., Bichet S., Marti H.H., Wenger R.H., Rivas L.A., Bauer C., and Gassmann M. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 3717-3720
21. Digicaylioglu M., and Lipton S.A. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412 (2001) 641-647
22. Ehrenreich H., Degner D., Meller J., Brines M., Behe M., Hasselblatt M., Woldt H., Falkai P., Knerlich F., Jacob S., von Ahsen N., Maier W., Bruck W., Ruther E., Cerami A., Becker W., and Siren A.L. Erythropoietin: a candidate compound for neuroprotection in schizophrenia. Mol. Psychiatry. 9 (2004) 42-54
23. Figueroa Y.G., Chan A.K., Ibrahim R., Tang Y., Burow M.E., Alam J., Scandurro A.B., and Beckman B.S. NF-kappaB plays a key role in hypoxia-inducible factor-1-regulated erythropoietin gene expression. Exp. Hematol. 30 (2002) 1419-1427
24. Fisher J.W. Erythropoietin: physiology and pharmacology update. Exp. Biol. Med. (Maywood) 228 (2003) 1-14
25. Frantseva M.V., Carlen P.L., and El-Beheiry H. A submersion method to induce hypoxic damage in organotypic hippocampal cultures. J. Neurosci. Methods 89 (1999) 25-31
26. Frotscher M., Heimrich B., and Schwegler H. Plasticity of identified neurons in slice cultures of hippocampus: a combined Golgi/electron microscopic and immunocytochemical study. Prog. Brain Res. 83 (1990) 323-339
27. Gahwiler B.H. Development of the hippocampus in vitro: cell types, synapses and receptors. Neuroscience 11 (1984) 751-760
28. Gahwiler B.H. Organotypic cultures of neural tissue. Trends Neurosci. 11 (1988) 484-489
29. Gahwiler B.H., Capogna M., Debanne D., McKinney R.A., and Thompson S.M. Organotypic slice cultures: a technique has come of age. Trends Neurosci. 20 (1997) 471-477
30. Genc S., Koroglu T.F., and Genc K. Erythropoietin and the nervous system. Brain Res. 1000 (2004) 19-31
31. Genc S., Koroglu T.F., and Genc K. Erythropoietin as a novel neuroprotectant. Restor. Neurol. Neurosci. 22 (2004) 105-119
32. Hanazono Y., Sasaki K., Nitta H., Yazaki Y., and Hirai H. Erythropoietin induces tyrosine phosphorylation of the beta chain of the GM-CSF receptor. Biochem. Biophys. Res. Commun. 208 (1995) 1060-1066
33. Ihle J.N., Witthuhn B.A., Quelle F.W., Yamamoto K., and Silvennoinen O. Signaling through the hematopoietic cytokine receptors. Annu. Rev. Immunol. 13 (1995) 369-398
34. Jubinsky P.T., Krijanovski O.I., Nathan D.G., Tavernier J., and Sieff C.A. The beta chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor. Blood 90 (1997) 1867-1873
35. Juul S.E., Anderson D.K., Li Y., and Christensen R.D. Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr. Res. 43 (1998) 40-49
36. Juul S.E., Yachnis A.T., Rojiani A.M., and Christensen R.D. Immunohistochemical localization of erythropoietin and its receptor in the developing human brain. Pediatr. Dev. Pathol. 2 (1999) 148-158
37. Kawakami M., Sekiguchi M., Sato K., Kozaki S., and Takahashi M. Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia. J. Biol. Chem. 276 (2001) 39469-39475
38. Leist M., Ghezzi P., Grasso G., Bianchi R., Villa P., Fratelli M., Savino C., Bianchi M., Nielsen J., Gerwien J., Kallunki P., Larsen A.K., Helboe L., Christensen S., Pedersen L.O., Nielsen M., Torup L., Sager T., Sfacteria A., Erbayraktar S., Erbayraktar Z., Gokmen N., Yilmaz O., Cerami-Hand C., Xie Q.W., Coleman T., Cerami A., and Brines M. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305 (2004) 239-242
39. Marti H.H., Wenger R.H., Rivas L.A., Straumann U., Digicaylioglu M., Henn V., Yonekawa Y., Bauer C., and Gassmann M. Erythropoietin gene expression in human, monkey and murine brain. Eur.J. Neurosci. 8 (1996) 666-676
40. Martin S.J., O'Brien G.A., Nishioka W.K., Mcgahon A.J., Mahboubi A., Saido T.C., and Green D.R. Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J. Biol. Chem. 270 (1995) 6425-6428
41. Masuda S., Nagao M., Takahata K., Konishi Y., Gallyas Jr. F., Tabira T., and Sasaki R. Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells. J. Biol. Chem. 268 (1993) 11208-11216
42. Matsushita H., Johnston M.V., Lange M.S., and Wilson M.A. Protective effect of erythropoietin in neonatal hypoxic ischemia in mice. Neuroreport 14 (2003) 1757-1761
43. Monyer H., Burnashev N., Laurie D.J., Sakmann B., and Seeburg P.H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron. 12 (1994) 529-540
44. Nagai A., Nakagawa E., Choi H.B., Hatori K., Kobayashi S., and Kim S.U. Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture. J. Neuropathol. Exp. Neurol. 60 (2001) 386-392
45. Nath R., Raser K.J., Mcginnis K., Nadimpalli R., Stafford D., and Wang K.K. Effects of ice-like protease and calpain inhibitors on neuronal apoptosis. Neuroreport 8 (1996) 249-255
46. Nath R., Raser K.J., Stafford D., Hajimohammadreza I., Posner A., Allen H., Talanian R.V., Yuen P., Gilbertsen R.B., and Wang K.K. Non-erythroid alpha-spectrin breakdown by calpain and interleukin 1 beta-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis. Biochem. J. 319 PT 3 (1996) 683-690
47. Noraberg J., Kristensen B.W., and Zimmer J. Markers for neuronal degeneration in organotypic slice cultures. Brain Res. Brain Res. Protoc. 3 (1999) 278-290
48. Ruscher K., Freyer D., Karsch M., Isaev N., Megow D., Sawitzki B., Priller J., Dirnagl U., and Meisel A. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J. Neurosci. 22 (2002) 10291-10301
49. Saido T.C., Sorimachi H., and Suzuki K. Calpain: new perspectives in molecular diversity and physiological-pathological involvement. Faseb. J. 8 (1994) 814-822
50. Sasaki R. Pleiotropic functions of erythropoietin. Intern. Med. 42 (2003) 142-149
51. Scott C.L., Robb L., Papaevangeliou B., Mansfield R., Nicola N.A., and Begley C.G. Reassessment of interactions between hematopoietic receptors using common beta-chain and interleukin-3-specific receptor beta-chain-null cells: no evidence of functional interactions with receptors for erythropoietin, granulocyte colony-stimulating factor, or stem cell factor. Blood 96 (2000) 1588-1590
52. Siman R., and Noszek J.C. Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo. Neuron. 1 (1988) 279-287
53. Siren A.L., Fratelli M., Brines M., Goemans C., Casagrande S., Lewczuk P., Keenan S., Gleiter C., Pasquali C., Capobianco A., Mennini T., Heumann R., Cerami A., Ehrenreich H., and Ghezzi P. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 4044-4049
54. Stoppini L., Buchs P.A., and Muller D. A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods 37 (1991) 173-182
55. Vaziri N.D., Zhou X.J., Smith J., Oveisi F., Baldwin K., and Purdy R.E. In vivo and in vitro pressor effects of erythropoietin in rats. Am. J. Physiol. 269 (1995) F838-F845
56. Wang K.K., and Yuen P.W. Calpain inhibition: an overview of its therapeutic potential. Trends Pharmacol. Sci. 15 (1994) 412-419
57. Zimmer J., and Gahwiler B.H. Cellular and connective organization of slice cultures of the rat hippocampus and fascia dentata. J. Comp. Neurol. 228 (1984) 432-446